Adrenal cortical carcinoma: the role of adjuvant postoperative chemotherapy.
Burgess
M A
MA
University of Texas, M.D. Anderson Cancer Center, Division of Medical Oncology, Houston, USA.
D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D000315:Adrenalectomy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008939:Mitotane / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D015996:Survival Rate; D013781:Texas / Q000453:epidemiology
D005047:Etoposide; D008939:Mitotane; D004317:Doxorubicin; D002945:Cisplatin